Relationship between oral amiodarone and inappropriate therapy from an implantable cardioverter defibrillator

Circulation Journal

Volumn 74, Issue 7, 2010, Pages 1302-1307

  Nagai, Takayuki ^a   Satomi, Kazuhiro ^a   Noda, Takashi ^a   Okamura, Hideo ^a   Yamada, Yuko ^a   Shimizu, Wataru ^a   Suyama, Kazuhiro ^a   Aihara, Naohiko ^a   Kamakura, Shiro ^a   Kurita, Takashi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Amiodarone; Atrial fibrillation; Implantable cardioverter defibrillator; Inappropriate therapy

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART BEAT; HEART DISEASE; HEART EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LIVER DYSFUNCTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PREDICTION; SUPRAVENTRICULAR TACHYCARDIA; THYROID DISEASE; HEART DISEASES; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT FAILURE;

AGED; AMIODARONE; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 77954521163     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0789     Document Type: Article

References (22)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amio-darone. Circulation 2000; 101: 1297-1302.
3. Kuck KH, Cappato R, Siebels J, Ruppel F, for the CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754.
4. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
6. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
8. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-594.
9. Carroll DL, Hamilton GA. Quality of life in implanted cardioverter defibrillator recipients: The impact of a device shock. Heart Lung 2005; 34: 169-178.
10. Herrmann C, von zur Muhen F, Schaumann A, Buss U, Kemper S, Wantzen C, et al. Standardized assessment of psychological well-being and quality of life in patients with implanted defibrillators. Pacing Clin Electrophysiol 1997; 20: 95-103.
11. Theuns DA, Klootwijk AP, Simoons ML, Jordaens LJ. Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathy. Am J Cardiol 2005; 95: 271-274.
12. Nanthakumar K, Dorian P, Paquette M, Greene M, Edwards J, Heng D, et al. Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol 2003; 8: 215-220.
13. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. JAMA 2006; 295: 165-171.
14. Satomi K, Kurita T, Takatsuki S, Yokoyama Y, Chinushi M, Tsuboi N, et al. Amiodarone therapy in patients implanted with car-dioverter-defibrillator for life-threatening ventricular arrhythmias. Circ J 2006; 70: 977-984.
15. Lee CH, Nam GB, Park HG, Kim HY, Park KM, Kim J, et al. Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators. Circ J 2008; 72: 102-105.
16. Aiba T, Yamagata K, Shimizu W, Taguchi A, Satomi K, Noda T, et al. Electrophysiologic study-guided amiodarone for sustained ventricular tachyarrhythmias associated with structural heart diseases. Circ J 2008; 72: 88-93.
17. AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol 2003; 42: 20-29.
18. Kochiadakis GE, Igoumenidis NE, Marketou ME, Solomou MC, Kanoupakis EM, Vardas PE. Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 1998; 81: 995-998.
19. Singh SN, Poole J, Anderson J, Hellkamp AS, Karasik P, Mark DB, et al. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am Heart J 2006; 152: 974.e7-e11.
20. Nul DR, Doval HC, Grancelli HO, Varini SD, Soifer S, Perrone SV, et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure: The GESICA-GEMA Investigators [Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicentricos en Argentina]. J Am Coll Cardiol 1997; 29: 1199-1205.
21. Satomi K, Kurita T, Takatsuki S, Yokoyama Y, Chinushi M, Tsuboi N, et al. Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias. Circ J 2006; 70: 977-984.
22. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: The detect supraventricular tachycardia study. Circulation 2006; 113: 2871-2879.